These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5155353)

  • 1. [Relationship between the formulation of a tablet and liberation of the active substance].
    Alexis MJ; Baudon MP; Delatre ML; de Mecheleer A; Jehotte MJ; Leduc MP; Leloup MJ; Mathieu MJ; Moran I; Roland MM; Stein J
    J Pharm Belg; 1971; 26(3):252-71. PubMed ID: 5155353
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative evaluation of some alginates as tablet disintegrants.
    Khan KA; Rhodes CT
    Pharm Acta Helv; 1972 Jan; 47(1):41-50. PubMed ID: 5013186
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biopharmacy and pharmacopoeias].
    Mirimanoff A
    Pharm Acta Helv; 1971 Mar; 46(3):129-33. PubMed ID: 5550116
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in tablet technology.
    Cooper J
    Adv Pharm Sci; 1971; 3():1-106. PubMed ID: 4947390
    [No Abstract]   [Full Text] [Related]  

  • 7. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of surface color as an expedient QC method for the detection of deviations in tablet hardness.
    Siddiqui A; Nazzal S
    Int J Pharm; 2007 Aug; 341(1-2):173-80. PubMed ID: 17499947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of hardness and solution rate of tablets as a function of the compression force].
    Delonca H; Puech A; Youakim J; Segura G
    J Pharm Belg; 1967; 22(5):209-12. PubMed ID: 5615275
    [No Abstract]   [Full Text] [Related]  

  • 10. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 3. Effect of lubricants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):476-8. PubMed ID: 4767501
    [No Abstract]   [Full Text] [Related]  

  • 12. Search for technological reasons to develop a capsule or a tablet formulation with respect to wettability and dissolution.
    von Orelli J; Leuenberger H
    Int J Pharm; 2004 Dec; 287(1-2):135-45. PubMed ID: 15541920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of powder characteristics on oral tablet disintegration.
    Yamamoto Y; Fujii M; Watanabe K; Tsukamoto M; Shibata Y; Kondoh M; Watanabe Y
    Int J Pharm; 2009 Jan; 365(1-2):116-20. PubMed ID: 18804156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological and in vitro availability].
    Speiser P
    Pharm Acta Helv; 1971 Aug; 46(8):449-67. PubMed ID: 5092965
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in drug technology in the years 1968 and 1969].
    Chalabala M; Malý J; Burelová A
    Cesk Farm; 1970 Nov; 19(9):332-60. PubMed ID: 4926371
    [No Abstract]   [Full Text] [Related]  

  • 16. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formulation of drugs and liberation of active ingredients].
    Libický A
    Cesk Farm; 1976 Dec; 25(10):420-4. PubMed ID: 1022336
    [No Abstract]   [Full Text] [Related]  

  • 18. An automatic multiple channel apparatus for dissolution studies under sink conditions and the method of data collection and computation.
    Fatton R; Fielding D; Khanna SC; Richter A
    Pharm Acta Helv; 1972; 47(8):487-94. PubMed ID: 5076847
    [No Abstract]   [Full Text] [Related]  

  • 19. Cohesive pharmaceutical powders.
    Pilpel N
    Adv Pharm Sci; 1971; 3():173-219. PubMed ID: 4947389
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of methaqualone.
    Smyth RD; Lee JK; Polk A; Chemburkar PB; Savacool AM
    J Clin Pharmacol; 1973 Oct; 13(10):391-400. PubMed ID: 4490663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.